| Issuer | % of Class | Filed |
|---|---|---|
|
Lyell Immunopharma, Inc.
13G/A
Amendment 1
LYEL · 55083R203
|
12.3% |
6/18/2026
Event 5/18/2026
|
|
Lyell Immunopharma, Inc.
13G
LYEL · 55083R203
|
9.8% |
11/13/2025
Event 11/6/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.